• Innovation
Health for all

Pharmaceuticals

The goal of Pharmaceuticals is to maintain its leading position in all areas of medicine and pharmacology in which it operates in Slovakia. Bayer Pharmaceuticals concentrates its knowledge and expertise in the following five strategic areas: Cardiovascular, Ophthalmology, Oncology, Women´s Health, Radiology and Special therapies. 

2019 7731
patient during examination

Clinical Trials

The research and development team in Slovakia conducts clinical trials in phases II to III. Clinical trials are one of the most important parts of new drug research and development. Depending on their phase, they are intended, in particular, to determine the efficacy of the drug, determine its dose, monitor its effects on the human body and monitor the safety of the medicine when taken, before and after marketing. For Slovak doctors, clinical trials are an opportunity to learn about new treatment options and allow them to participate in the development of new medicines in collaboration with experts from other countries. Clinical trials are conducted under the guidance of selected physicians on the so-called clinical trials centers in several therapeutic areas, in particular in the field of hematooncology, oncology, cardiology and gynecology. Patients are given the opportunity to try innovative treatment for their disease and receive more intensive care. 

Reporting of an adverse drug reaction / Hlásenie nežiadúceho účinku lieku

Bayer spol. s. r. o.
Pharmacovigilance / Oddelenie farmakovigilancie
Twin City, blok A, Karadžičova 2, 811 09 Bratislava
pv.cee@bayer.com
Tel: +421 2 592 13 321

Spontaneous reporting form of suspected adverse drug reaction / Hlásenie podozrenia na nežiaduci účinok lieku

If any of the above-mentioned contacts are used for reporting adverse reactions, I take note of the related Privacy Statement for Pharmacovigilance. 

V prípade využitia niektorého z vyššie uvedených kontaktov pre hlásenia nežiaducich účinkov beriem na vedomie súvisiace Vyhlásenie o ochrane osobných údajov pre farmakovigilanciu.

Reporting of a falsification or suspected drug defect / Hlásenie falšovania alebo podozrenia na chybu lieku

quality.sk@bayer.com 
Tel: +421 2 592 13 321

If you use any of the above contacts to report a suspected quality defect, a complaint about use or a suspected counterfeit, you take note of the Declaration on the processing of personal data for quality assurance. 

V prípade použitia ktoréhokoľvek z vyššie uvedených kontaktov na nahlásenie podozrenia závady v kvalite, sťažností súvisiacich s užívaním alebo podozrenia na falzifikát, beriem na vedomie Vyhlásenie o spracovaní osobných údajov na zabezpečenie kvality.